Mark Sirgo

Type: Person
Name: Mark Sirgo
First reported Oct 29 2014 - Updated Oct 29 2014 - 1 reports

BDSI aiming to develop injectable buprenorphine

BioDelivery Sciences International ( $BDSI ) is partnering with Evonik to develop a formulation of buprenorphine that can be subcutaneously injected and provide continuous therapy for 30 days. BDSI will pursue an approval for opioid dependence in about ... [Published Fierce Drug Delivery - Oct 29 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

BioDelivery Sciences International's CEO Presents at BioDelivery Sciences to Provide BUNAVAIL Launch Update (Transcript)

OperatorGood day, ladies and gentlemen. Welcome to the BioDelivery Sciences Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. Instructions will follow at that time. (Operator ... [Published Seeking Alpha - Oct 07 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

BioDelivery Sciences to Present at the Morgan Stanley Global Healthcare Conference

RALEIGH, N.C., Sept. 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Morgan Stanley Global Healthcare Conference.  ... [Published PR Newswire: General Business - Sep 08 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

'Fast Money' Recap: The European Central Bank and Bonds

a NEW YORK (TheStreet) -- The S&P 500 slid 0.15% while the iShares 20+ Year Treasury Bond ETFfell 1.22% and is down 2.6% on the week.aOn CNBC's "Fast Money" TV show, Guy Adami, managing director of stockmonster.com, said he remains bullish on bonds and ... [Published The Street Latest - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

BioDelivery Sciences to Ring The NASDAQ Stock Market Opening Bell

RALEIGH, N.C., Sept. 3, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the company will visit the NASDAQ MarketSite in Times Square on September 4, 2014.  In honor of the occasion, Dr. Mark A. Sirgo, President ... [Published PR Newswire: Health - Sep 03 2014]
First reported Jun 11 2014 - Updated Jun 12 2014 - 1 reports

BioDelivery Sciences Featured on Bloomberg TV, TheStreet.com and Business News Network

RALEIGH, N.C., June 11, 2014 /PRNewswire/ -- Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) was interviewed on Bloomberg TV, TheStreet.com and Business News Network on June 11 regarding ... [Published PR Newswire: Entertainment & Media - Jun 11 2014]
First reported Jun 10 2014 - Updated Jun 10 2014 - 1 reports

US FDA approves BioDelivery Sciences' Bunavail buccal film for maintenance treatment of opioid dependence

BioDelivery Sciences International, Inc. received approval of the New Drug Application (NDA) for Bunavail (buprenorphine and naloxone) buccal film (CIII) from the US Food and Drug Administration (US FDA). Bunavail is indicated for the maintenance treatment ... [Published PharmaBiz - Jun 10 2014]
First reported Jun 10 2014 - Updated Jun 10 2014 - 1 reports

BioDelivery Sciences to Present at the William Blair and Wells Fargo Healthcare Conferences

RALEIGH, N.C., June 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at two important upcoming healthcare conferences: 34th ... [Published PR Newswire: General Business - Jun 10 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Bank of America Merrill Lynch 2014 Health Care Conference.  ... [Published PR Newswire: General Business - May 08 2014]

More Content

All (9) | News (4) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
BDSI aiming to develop injectable buprenorphine [Published Fierce Drug Delivery - Oct 29 2014]
BioDelivery Sciences International's CEO Presen... [Published Seeking Alpha - Oct 07 2014]
BioDelivery Sciences to Present at the Morgan S... [Published PR Newswire: General Business - Sep 08 2014]
'Fast Money' Recap: The European Central Bank a... [Published The Street Latest - Sep 05 2014]
BioDelivery Sciences to Ring The NASDAQ Stock M... [Published PR Newswire: Health - Sep 03 2014]
BioDelivery Sciences Featured on Bloomberg TV, ... [Published PR Newswire: Entertainment & Media - Jun 11 2014]
BioDelivery Sciences to Present at the William ... [Published PR Newswire: General Business - Jun 10 2014]
US FDA approves BioDelivery Sciences' Bunavail ... [Published PharmaBiz - Jun 10 2014]
BioDelivery Sciences to Present at the Bank of ... [Published PR Newswire: General Business - May 08 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioDelivery Sciences to Present at the Morgan S... [Published PR Newswire: General Business - Sep 08 2014]
RALEIGH, N.C., Sept. 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Morgan Stanley Global Healthcare Conference.  ...
BioDelivery Sciences to Ring The NASDAQ Stock M... [Published PR Newswire: Health - Sep 03 2014]
RALEIGH, N.C., Sept. 3, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the company will visit the NASDAQ MarketSite in Times Square on September 4, 2014.  In honor of the occasion, Dr. Mark A. Sirgo, President ...
BioDelivery Sciences Featured on Bloomberg TV, ... [Published PR Newswire: Entertainment & Media - Jun 11 2014]
RALEIGH, N.C., June 11, 2014 /PRNewswire/ -- Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) was interviewed on Bloomberg TV, TheStreet.com and Business News Network on June 11 regarding ...
BioDelivery Sciences to Present at the William ... [Published PR Newswire: General Business - Jun 10 2014]
RALEIGH, N.C., June 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at two important upcoming healthcare conferences: 34th ...
BioDelivery Sciences to Present at the Bank of ... [Published PR Newswire: General Business - May 08 2014]
RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Bank of America Merrill Lynch 2014 Health Care Conference.  ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.